Research Briefs: Data From Intersect ENT, BioVentrix and Hologic

Encouraging pilot trial results on a drug-eluting implant for sinusitis made by Intersect ENT. First-in-man procedure with myocardial anchoring system for heart failure from BioVentrix. Final analysis of registry data confirms the efficacy of Hologic’s MammoSite breast brachytherapy system.

More from Archive

More from Medtech Insight